简介：
Overview
This protocol outlines a rapid seven-day workflow for assessing drug responses in human acute lymphoblastic leukemia (ALL) using zebrafish embryos. It details the generation of xenografts from patient-derived leukemia cells and provides insights into adapting the method for solid tumors.
Key Study Components
Area of Science
- Oncology
- Pharmacology
- Preclinical Models
Background
- Human acute lymphoblastic leukemia (ALL) is a pediatric cancer.
- Zebrafish embryos serve as a unique preclinical model for studying cancer.
- Access to rare cancer samples enhances the relevance of the study.
- Drug penetration and pharmacokinetics are critical for effective treatment assessment.
Purpose of Study
- To develop a protocol for generating xenografts from ALL and solid tumors.
- To evaluate drug responses in a clinically relevant model.
- To improve the survival of graft cells by blocking immune differentiation.
Methods Used
- Generation of xenografts from cell lines and fresh patient material.
- Transient immunosuppression of zebrafish embryos.
- Flow cytometry for assessing single cell viability and proliferation.
- Testing drug penetration before experimental trials.
Main Results
- Successful growth of patient-derived leukemia cells in zebrafish.
- Adaptation of the protocol for solid pediatric tumors.
- Effective measurement of drug responses using flow cytometry.
- Improved graft cell survival through immune cell differentiation blockade.
Conclusions
- The zebrafish model is a promising tool for pediatric oncology research.
- Drug response assessment can be effectively conducted in this model.
- Future studies may expand to other types of pediatric tumors.
What types of cancer can be studied using this protocol?
This protocol is designed for human acute lymphoblastic leukemia (ALL) and can be adapted for solid pediatric tumors.
How does the zebrafish model benefit cancer research?
Zebrafish embryos provide a unique preclinical model that allows for the study of drug responses in a living organism.
What is the significance of using flow cytometry in this study?
Flow cytometry allows for precise measurement of single cell viability and proliferation, which is crucial for assessing drug responses.
Why is pharmacokinetics important in this research?
Understanding pharmacokinetics ensures that drugs can effectively penetrate biological barriers to reach the target cells.
What is the duration of the experimental workflow?
The experimental workflow is designed to be completed in seven days.
How does the protocol address immune cell differentiation?
The protocol includes methods to block innate immune cell differentiation, enhancing the survival of graft cells.
繁體中文
